1 – 100 of 459
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
(
- Contribution to journal › Article
-
Mark
Eight Misconceptions about Prostate-Specific Antigen
(
- Contribution to journal › Article
-
Mark
Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial
2024) In European Urology(
- Contribution to journal › Article
-
Mark
Transcriptome-Wide Association Analysis Identifies Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer
2024) In Human Genetics and Genomics Advances(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI : The ProScreen Randomized Trial
(
- Contribution to journal › Article
- 2023
-
Mark
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality : 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial
(
- Contribution to journal › Article
-
Mark
Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
(
- Contribution to journal › Letter
-
Mark
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
(
- Contribution to journal › Article
-
Mark
Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Transcriptome-Wide Association Analysis Identifies Novel Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer
2023) p.1-36(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Genetically adjusted PSA levels for prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)(
- Contribution to conference › Abstract
-
Mark
Acoustophoresis enriches tumor cell clusters in blood of patients with prostate cancer
2023) Acoustofluidics Conference 2023, St. Louis USA(
- Contribution to conference › Abstract
-
Mark
Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen : a pilot study
(
- Contribution to journal › Article
-
Mark
Prostate cancer polygenic risk score and prediction of lethal prostate cancer
(
- Contribution to journal › Article
-
Mark
Association of Prostate-Specific Antigen Levels with Prostate Cancer Risk in a Multiethnic Population : Stability over Time and Comparison with Polygenic Risk Score
2022) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31(12). p.2199-2207(
- Contribution to journal › Article
-
Mark
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
PSA : role in screening and monitoring patients with prostate cancer
2022) p.131-172(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial
(
- Contribution to journal › Article
-
Mark
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
(
- Contribution to journal › Article
-
Mark
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
(
- Contribution to journal › Article
- 2021
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
(
- Contribution to journal › Article
-
Mark
Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing
(
- Contribution to journal › Article
-
Mark
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort
(
- Contribution to journal › Article
-
Mark
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): : initial results from an international prospective study
(
- Contribution to journal › Article
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
(
- Contribution to journal › Article
-
Mark
Modern prostate cancer diagnostics reduce overdiagnosis–will they open up for population-based screening?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood
(
- Contribution to journal › Article
- 2020
-
Mark
Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels
(
- Contribution to journal › Article
-
Mark
Reply by Authors
(
- Contribution to journal › Article
-
Mark
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate
(
- Contribution to journal › Article
-
Mark
The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population
2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(7). p.1381-1388(
- Contribution to journal › Article
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181(
- Contribution to journal › Article
-
Mark
Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB
(
- Contribution to journal › Article
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years
(
- Contribution to journal › Article
-
Mark
Reply by Authors
(
- Contribution to journal › Article
-
Mark
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years : A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
(
- Contribution to journal › Article
- 2019
-
Mark
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Prostate cancer risk-associated single-nucleotide polymorphism affects prostate-specific antigen glycosylation and its function
(
- Contribution to journal › Article
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
(
- Contribution to journal › Article
-
Mark
Perspective on prostate cancer screening
(
- Contribution to journal › Scientific review
-
Mark
Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men
(
- Contribution to journal › Article
-
Mark
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
2019) In Prostate(
- Contribution to journal › Article
-
Mark
The role of plasma microseminoprotein-beta in prostate cancer : An observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
A urinary extracellular vesicle microRNA biomarker discovery pipeline; from automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing
(
- Contribution to journal › Article
-
Mark
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
(
- Contribution to journal › Article
-
Mark
A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy : An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re : Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961–7
(
- Contribution to journal › Letter
-
Mark
Clinical chemistry’s special issue on men’s health
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men
(
- Contribution to journal › Article
-
Mark
Association Between Lead Time and Prostate Cancer Grade : Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening
(
- Contribution to journal › Article
-
Mark
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
(
- Contribution to journal › Article
-
Mark
Value of Intact Prostate Specific Antigen and Human Kallikrein 2 in the 4 Kallikrein Predictive Model : An Individual Patient Data Meta-Analysis
(
- Contribution to journal › Article
-
Mark
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
(
- Contribution to journal › Article
-
Mark
Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL : results from the Göteborg randomized population-based prostate cancer screening trial
(
- Contribution to journal › Article
-
Mark
Re : Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46
(
- Contribution to journal › Letter
-
Mark
Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival
(
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Extracellular Vesicles from Biological Fluids
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age : Data from the malmö preventive project
(
- Contribution to journal › Article
-
Mark
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial : effect of sociodemographic variables on participation, prostate cancer incidence and mortality
(
- Contribution to journal › Article
-
Mark
Reducing WBC background in cancer cell separation products by negative acoustic contrast particle immuno-acoustophoresis
(
- Contribution to journal › Article
-
Mark
Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts
(
- Contribution to journal › Article
- 2017
-
Mark
Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer
(
- Contribution to journal › Article
-
Mark
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study
(
- Contribution to journal › Article
-
Mark
Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood
(
- Contribution to journal › Article
-
Mark
Vasectomy and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
(
- Contribution to journal › Article
- 2016
-
Mark
Porous silicon microarray for simultaneous fluorometric immunoassay of the biomarkers prostate-specific antigen and human glandular kallikrein 2
(
- Contribution to journal › Article
-
Mark
Beyond prostate-specific antigen : Utilizing novel strategies to screen men for prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel
2016) In Journal of Urology(
- Contribution to journal › Article
-
Mark
Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice : A microsimulation screening analysis
(
- Contribution to journal › Article
-
Mark
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
(
- Contribution to journal › Article
-
Mark
Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections
(
- Contribution to journal › Article
-
Mark
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Reply to Re : The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening
(
- Contribution to journal › Letter
-
Mark
The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening
(
- Contribution to journal › Article
-
Mark
Author Reply
(
- Contribution to journal › Letter
- 2015
-
Mark
Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial.
(
- Contribution to journal › Article
-
Mark
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
(
- Contribution to journal › Article
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
(
- Contribution to journal › Article
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
(
- Contribution to journal › Article
-
Mark
A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
-
Mark
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study.
(
- Contribution to journal › Article
-
Mark
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
A single inlet two-stage acoustophoresis chip enabling tumor cell enrichment from white blood cells
(
- Contribution to journal › Article
-
Mark
Concurrent Isolation of Lymphocytes and Granulocytes Using Prefocused Free Flow Acoustophoresis
(
- Contribution to journal › Article
-
Mark
Acoustofluidic, label-free separation and simultaneous concentration of rare tumor cells from white blood cells
(
- Contribution to journal › Article
-
Mark
Serum markers in prostate cancer detection.
(
- Contribution to journal › Article
-
Mark
Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.
(
- Contribution to journal › Article
-
Mark
Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.
2015) In Oncotarget(
- Contribution to journal › Article